U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07169422) titled 'Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care' on Aug. 30.
Brief Summary: Type 2 diabetes is the leading cause of chronic kidney disease, which can result in serious complications such as kidney failure and heart disease. Although effective medications exist to slow the progression of kidney damage, they are often underused in primary care, particularly for individuals without a regular family doctor. In response to this gap, 46 community pharmacy-led primary care clinics were launched across Nova Scotia in 2023 to serve under-resourced areas. Pharmacists at these clinics can prescrib...